- The relatively less known VanEck's BBH has delivered a better one-year performance than the popular iShares' IBB.
- The reason is that BBH dedicates a higher percentage of assets to Covid stocks.
- Demand for Covid diagnostics and vaccines should be sustained as large populations and age groups remain unvaccinated.
- Still, with the emergence of the Omicron strain, BBH is not immune to intense periods of volatility as seen in the way it has historically trended.
- The ETF's outperformance with respect to IBB looks to continue and it provides better dividends too.
For further details see:
BBH: Better Than IBB For Covid Exposure Including The Omicron Variant